The second is gastrointestinal inflammation: BPC-157s gastric origin gives it exceptional affinity for gut tissue, and the preclinical data on gut permeability, mucosal repair, and intestinal motility is the strongest body of evidence for this compound
Along with fully counteracted severe muscle disturbances, there were brain, heart, lung, liver, kidney and gastrointestinal tract lesions, along with progressing venous and arterial thrombosis progressing stasis, both peripherally and centrally, all of which were counteracted by BPC 157 therapy application
Timing: Best taken on an empty stomach or 30 minutes before meals for improved absorption
The future of peptides in the US is about to become clearer
The report was reformatted, additional pages were added, and internal authorization fields not present on the original Vanguard report, including a signature attributed to Patrick La Rive, PhD, CEO/President were added